Pull to refresh
Logo
FDA clears AI software that turns MRI scans into body composition analysis

FDA clears AI software that turns MRI scans into body composition analysis

New Capabilities

AIRS Medical's SwiftSight quantifies muscle, fat, and liver fat from a five-minute MRI scan; SimonMed Imaging is first to deploy

Today: AIRS Medical announces clearance

Overview

Updated 2 hours ago

A five-minute MRI scan can now produce a detailed breakdown of a patient's muscle, fat, and liver fat. The FDA cleared AIRS Medical's SwiftSight Body Composition on October 1, and SimonMed Imaging will be the first imaging network to deploy it.

The software automates what radiologists have judged by eye: it quantifies visceral and subcutaneous fat, muscle quality, and liver fat, then benchmarks results against age- and sex-matched reference populations. Because MRI uses no ionizing radiation, the same scan can be repeated over time to track changes.

Why it matters

BMI can't show where fat sits or how much muscle a patient carries. This software turns existing MRI machines into automated body composition analyzers.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

5 min
MRI scan time
SwiftSight Body Composition runs on a scan under five minutes.
139 days
FDA review time
Traditional 510(k) review from submission on May 15 to clearance on October 1.
1
First deployment customer
SimonMed Imaging will be the first network to deploy the cleared software.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

May 2026 October 2026

3 events Latest: Today
  1. AIRS Medical announces clearance

    Today Announcement

    Company announces FDA clearance; SimonMed Imaging named as first deployment customer.

  2. FDA clears SwiftSight Body Composition

    Regulatory

    FDA clears K261612 after 139-day review, finding it substantially equivalent to a predicate device.

  3. 510(k) submitted to FDA

    Regulatory

    AIRS Medical files SwiftSight Body Composition for Traditional 510(k) review.

Scenarios

1

Body composition MRI becomes a standard metabolic health screen

Possible Resolves by End of 2027

Discussed by: AIRS Medical's product roadmap and imaging industry analysts

SimonMed deploys the software across multiple sites, and other imaging networks follow. The quantitative report becomes a standard add-on for preventive imaging, weight management, and healthy-aging programs, creating a new revenue line from existing MRI machines.

2

Stays a self-pay wellness add-on

Possible Resolves by End of 2027

Discussed by: iaica.com.cn analysis of payment and interpretation gaps

Without payer coverage, the service remains a cash-pay option at preventive imaging and longevity clinics. Adoption stays limited to high-end wellness programs, and the technology does not enter routine clinical care pathways.

3

Competitors enter the quantitative MRI market

Likely Resolves by End of 2027

Discussed by: Imaging industry observers tracking the AI MRI segment

Rival AI imaging vendors release similar FDA-cleared body composition tools, commoditizing the category. AIRS Medical's first-mover advantage narrows as the market shifts to price and workflow integration.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

1990

Coronary artery calcium scoring (1990)

Arthur Agatston published a method that quantified coronary artery calcium on CT scans, turning a qualitative image into a numeric risk score. The Agatston score gave cardiologists a reproducible number for cardiac risk.

Then

The score became a widely used research tool for cardiac risk assessment.

Now

It became a standard clinical test, though reimbursement battles lasted years before payers covered it.

Why this matters now

Shows how a quantitative imaging biomarker can move from research to clinical use, and how slowly payment follows the science.

1980s

DEXA bone densitometry (1980s)

Dual-energy X-ray absorptiometry emerged as a way to measure bone mineral density quantitatively, replacing subjective readings of bone loss on plain X-rays.

Then

DEXA became the standard tool for diagnosing osteoporosis and monitoring treatment.

Now

It established quantitative body measurement as a reimbursable clinical service.

Why this matters now

Body composition via MRI is the same kind of quantitative measurement, applied to fat and muscle instead of bone.

Sources

(7)